Basic Information
Kwivik Therapeutics Inc. has developed a new method for producing medical oxygen from two kinds of dry inert powders. The oxygen is generated on demand without the need for pressurized storage. By combining this "powder-to-oxygen" technology with innovative biotechnology, engineering, Internet of Things (IoT), and artificial intelligence technologies, we have created a series of powerful new products aimed at disrupting certain markets in respiratory care, emergency medicine, asthma treatment, cluster headache/migraine relief, wound care, and skincare.
Kwivik Therapeutics, Inc.
Texas,United States of America
15~50 people
July 21, 2016
kwivik@kwivikmedical.com

